Catecholamines block 2-hydroxyestradiol-induced antimitogenesis in mesangial cells

Hypertension

Volumn 39, Issue 4, 2002, Pages 854-859

  Zacharia, Lefteris C ^a   Jackson, Edwin K ^a   Gillespie, Delbert G ^a   Dubey, Raghvendra K ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Catecholamines; Estrogen; Glomerulosclerosis; Metabolism; Renal disease; Sympathetic nervous system

Indexed keywords

2 HYDROXYESTRADIOL; 2 METHOXYESTRADIOL; ADRENALIN; ANTIMITOTIC AGENT; CATECHOL METHYLTRANSFERASE; CATECHOLAMINE; NORADRENALIN; PROLINE; THYMIDINE;

ADRENERGIC SYSTEM; ANIMAL CELL; ARTICLE; CELL COUNT; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; MESANGIUM CELL; METHYLATION; MICHAELIS CONSTANT; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CATECHOLAMINES; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTRADIOL ANTAGONISTS; GLOMERULAR MESANGIUM; GROWTH INHIBITORS; KINETICS; PROLINE; RATS; RATS, SPRAGUE-DAWLEY; THYMIDINE;

EID: 0036241168     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000014502.44988.39     Document Type: Article

References (25)

1. Estrogen Induced cardiorenal protection: Potential cellular, biochemical, and molecular mechanisms
2. Effect of Gender on the progression of chronic renal disease: A meta analysis
3. The impact of gender on the progression of chronic renal disease
4. Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor independent mechanisms
5. Catecholamines abrogate the anti-mitogenic effects of 2-hydroxyestradiol on human aortic vascular smooth muscle cells
6. 17β-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth
7. Regulation of mesangial cell proliferation
8. Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth
9. Increased norepinephrine secretion in patients with the nephrotic syndrome and normal glomerular filtration rates: Evidence for primary sympathetic activation
10. Renal Afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in rats
11. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats
12. A possible role of catecholamines in atherogenesis and subsequent complications of atherosclerosis
13. Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors
14. Cyclooxygenase inhibition reveals synergistic action of vasoconstrictors on mesangial cell growth
15. Vascular effects of environmental estrogens: Implications for reproductive and vascular health
16. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice
17. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice
18. Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells
19. Formation, metabolism, and physiologic importance of catecholestrogens
20. 125I-labelled ligand
21. The sympathetic nervous system in human hypertension
22. Pathophysiology of pheochromocytoma
23. The synaptic noradrenaline concentration in humans as estimated from simultaneous measurements of plasma noradrenaline and dihydroxyphenylglycol (DOPEG)
24. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrate/nitrite) levels in postmenopausal women substituted with 17β-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate
25. Antioxidant protection of LDL by physiological concentrations of 17β-estradiol. Requirement for estradiol modification